A Phase 1, Randomized, Placebo- and Active-Controlled Crossover Study to Determine the Effect of Single-Dose Ertugliflozin on QTc Interval in Healthy Volunteers

Other posts you may like

JSOT 45

July 18-20, 2018 Osaka – JAPAN Join our luncheon seminar!

AFSTAL

June 13-15, 2018 Reims – FRANCE

Stay informed about our latest news and next user groups or exhibitions.

American Thoracic Society

May 18-23, 2018 San Diego,  California – USA Booth #1535